FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to a combination and a pharmaceutical preparation used for treating inflammatory for treating inflammatory and obstructive respiratory diseases. Said combination and preparation involve R,R-glycopyrrolate or its prolonged release physiologically acceptable salt and beta-mimetic agent selected from formoterol or salmeterol or their physiologically acceptable salts. Daily doses of said active ingredients make formoterol 1-72 mcg, salmeterol 10-300 mcg and R,R-glycopyrrolate 5-500 mcg.
EFFECT: invention provides a superadditive bronchospasmolytic effect with simultaneous reduction of side effects, and also anti-inflammatory action.
9 cl, 3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| COMBINATION OF R,R-GLYCOPYRROLATE AND MONTELUKAST FOR TREATMENT OF RESPIRATORY DISEASES AND BASED ON IT PHARMACEUTICAL COMPOSITION | 2006 |
|
RU2420285C2 |
| COMBINATION (VERSIONS) AND PHARMACEUTICAL PREPARATION FOR TREATMENT OF RESPIRATORY TRACT DISEASES | 2005 |
|
RU2437658C2 |
| COMBINATION (VERSIONS) AND PHARMACEUTICAL PREPARATION FOR TREATING UPPER RESPIRATORY TRACT DISEASES | 2005 |
|
RU2440813C2 |
| COMBINATION AND PHARMACEUTICAL PREPARATION FOR TREATMENT OF INFLAMMATORY DISEASES | 2006 |
|
RU2465915C2 |
| COMBINATIONS CONTAINING ANTI-MUSCARINE PREPARATIONS AND BETA-ADRENERGIC AGONISTS | 2005 |
|
RU2379033C2 |
| COMBINATIONS CONTAINING ANTIMUSCARINIC AGENTS AND BETA-ADRENERGIC AGONISTS | 2005 |
|
RU2404771C2 |
| COMPOSITIONS FOR PULMONARY DELIVERY OF LONG-ACTING MUSCARINIC ANTAGONISTS AND LONG-ACTING β-ADRENERGIC RECEPTOR AGONISTS AND RELATED METHODS AND SYSTEMS | 2010 |
|
RU2574893C2 |
| COMBINATIONS CONTAINING ANTIMUSCARINIC AGENTS AND PDE4 INHIBITORS | 2005 |
|
RU2373935C2 |
| PHARMACEUTICAL COMPOSITIONS | 2011 |
|
RU2568882C2 |
| COMBINATIONS, CONNECTING ANTI-MUSCARINIC PREPARATIONS AND BETA-ADRENERTIC AGONISTS | 2010 |
|
RU2465902C2 |
